Literature DB >> 7951231

Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.

J Sainz1, D P Huynh, K Figueroa, N K Ragge, M E Baser, S M Pulst.   

Abstract

Schwannomas are common tumors of the nervous system and are frequently found in patients with neurofibromatosis (NF) 2. Although loss of heterozygosity in NF2 tumors suggests that the NF2 gene functions as a tumor suppressor gene, the NF2 gene shows amino acid sequence homology to structural proteins in one of which dominantly acting mutations have been described. We performed a mutational analysis in 30 vestibular schwannomas and examined the effect of mutations on the NF2 protein. We detected 18 mutations in 30 vestibular schwannomas of which seven contained loss or mutation of both NF2 alleles. Most mutations were predicted to result in a truncated protein. Mutational hot spots were not identified. Immunocytochemical studies using antibodies to the NF2 protein showed complete absence of staining in tumor Schwann cells, whereas staining was observed in normal vestibular nerve. These data indicate that loss of NF2 protein function is a necessary step in schwannoma pathogenesis and that the NF2 gene functions as a recessive tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951231     DOI: 10.1093/hmg/3.6.885

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin.

Authors:  L R De Vitis; A Tedde; F Vitelli; F Ammannati; P Mennonna; P Bono; B Grammatico; P Grammatico; P Radice; U Bigozzi; E Montali; L Papi
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.

Authors:  S M Messerli; Y Tang; M Giovannini; R Bronson; R Weissleder; X O Breakefield
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 3.  The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Authors:  M E Baser; L Kuramoto; R Woods; H Joe; J M Friedman; A J Wallace; R T Ramsden; S Olschwang; E Bijlsma; M Kalamarides; L Papi; R Kato; J Carroll; C Lázaro; F Joncourt; D M Parry; G A Rouleau; D G R Evans
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

4.  Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.

Authors:  M Giovannini; E Robanus-Maandag; M Niwa-Kawakita; M van der Valk; J M Woodruff; L Goutebroze; P Mérel; A Berns; G Thomas
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

5.  Eleven novel mutations in the NF2 tumour suppressor gene.

Authors:  D Bourn; G Evans; S Mason; S Tekes; L Trueman; T Strachan
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

6.  Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.

Authors:  R P Stokowski; D R Cox
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

7.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Universal absence of merlin, but not other ERM family members, in schwannomas.

Authors:  A O Stemmer-Rachamimov; L Xu; C Gonzalez-Agosti; J A Burwick; D Pinney; R Beauchamp; L B Jacoby; J F Gusella; V Ramesh; D N Louis
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

9.  A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected].

Authors:  L Kluwe; S M Pulst; J Köppen; V F Mautner
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

10.  Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.

Authors:  Maurits de Vries; Inge Briaire-de Bruijn; Anne-Marie Cleton-Jansen; Martijn J A Malessy; Andel G L van der Mey; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2012-12-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.